Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Jay E. Gold"'
Publikováno v:
Journal of Surgical Research. 59:279-286
Autolymphocyte therapy (ALT) is adoptive cellular therapy of neoplastic disease based upon ex vivo activation of lymphocytes by either the supernatant derived from a previously prepared one-way mixed lymphocyte culture (MLC) or using low doses of the
Publikováno v:
Cancer. 75:2875-2878
Background. Carcinoma of the breast infrequently presents initially as axillary adenopathy. In such cases, after biopsy proves the presence of metastatic carcinoma, the primary tumor generally is assumed to be in the ipsilateral breast, despite negat
Publikováno v:
International Journal of Cancer. 61:580-586
Autolymphocyte therapy (ALT) is adoptive cellular therapy of neoplastic disease using ex vivo activation of autologous (human) or syngeneic (murine) lymphocytes from tumor-bearing hosts (TBH) by low doses of anti-CD3 monoclonal antibody (MAb) and a m
Autor:
Norman Bloom, Samuel Kenan, Michail Shafir, Jay E. Gold, Michael E. Osband, Ted R. Masters, Michael J. Klein
Publikováno v:
Journal of Surgical Oncology. 58:212-221
Autolymphocyte therapy (ALT) is tumor-specific, adoptive cellular therapy of neoplastic disease using nonspecific ex vivo activation of autologous peripheral blood lymphocytes (PBL), which are composed primarily of memory T-cells (ALT-cells) and are
Autor:
Michael E. Osband, Jay E. Gold
Publikováno v:
Clinical Immunology and Immunopathology. 71:325-332
Autolymphocyte therapy (ALT) is tumor-specific adoptive cellular therapy of neoplastic disease in human tumorbearing hosts based upon nonspecific ex vivo activation of autologous peripheral blood lymphocytes. We have previously demonstrated that nons
Publikováno v:
Cancer Treatment Reviews. 20:173-190
Publikováno v:
American Journal of Hematology. 44:42-47
Adoptively transferred immune cells in combination with chemotherapeutic agents form the basis for adoptive chemoimmunotherapy (ACIT) of neoplastic disease. Autolymphocytes (ALT-cells) are ex vivo activated peripheral blood lymphocytes (PBL) from tum
Publikováno v:
Journal of Immunotherapy. 13:213-221
Autolymphocytes (ALT cells) are ex vivo activated peripheral blood lymphocytes (PBL) from tumor-bearing hosts (TBH) that consist primarily of tumor specific CD45RO+ (memory) T cells. These ALT cells combined with cimetidine as autolymphocyte therapy
Autor:
Arvind Babu, Ralph Zalusky, Jay E. Gold, Violette Ghali, Daniel M. Knowles, Eleni Athan, John R. Little, Anthony Louis-Charles
Publikováno v:
Cancer. 70:86-93
BACKGROUND: Lymphocytes that display a phenotype of mature B-cells, T-cells, natural killer (NK) cells, or a combination of T-cells and NK cells can be found in patients with lymphoproliferations that manifest as expansions of peripheral blood lympho
Autor:
H. J. Ree, James P. Crowley, Ralph Zalusky, Hershel Kahn, Amjad A. Khan, Jay E. Gold, James A. Strauchen
Publikováno v:
Cancer. 67:1614-1621
Hodgkin's disease (HD) was diagnosed in 24 patients who were either seropositive for human immunodeficiency virus (HIV) (21) or members of a high-risk group (three), but had not developed acquired immune deficiency syndrome (AIDS). Clinical presentat